» Articles » PMID: 8666927

Distinct T Cell Receptor Signaling Requirements for Perforin- or FasL-mediated Cytotoxicity

Overview
Journal J Exp Med
Date 1996 Apr 1
PMID 8666927
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A diverse array of signals are generated in a cytotoxic T lymphocyte (CTL) after the T cell receptor (TCR) engages the class I major histocompatibility complex (MHC) peptide complex. These signals result in a multitude of CTL effector functions, including cellular cytotoxicity, cell surface receptor expression, and cytokine secretion. We have examined signaling through the TCR in a wild type CD8+, MHC-restricted, antigen-specific CTL clone, 14-7, and its interleukin 2-dependent variant clone 14-7FD. We report here that 14-7FD is unable to kill via the perforin mechanism of killing, yet is able to kill via the Fas ligand/Fas mechanism and secrete interferon-gamma in an antigen-specific manner. 14-7FD has cytolytic granules that contain perforin and serine esterases, which are secreted after phorbol ester and Ca2+ ionophore treatment. Lastly, to investigate which TCR signaling requirements were operational in 14-7FD, we examined TCR-triggered intracellular Ca2+ mobilization in the two clones. After TCR engagement, 14-7FD failed to mobilize intracellular Ca2+, which may be the cause for its inability to trigger the perforin/granule exocytosis mechanism of killing. These results indicate that the signal transduction events that trigger perforin killing and the signaling requirements to induce FasL expression are distinct. We hypothesize that these two distinct TCR signal transduction requirements allow for separate activation of these two mechanisms of killing relating to their role in eradication of infected cells or regulation of immune responses.

Citing Articles

Use of the Human Granulysin Transgenic Mice To Evaluate the Role of Granulysin Expression by CD8 T Cells in Immunity To Mycobacterium tuberculosis.

Thakur P, Sutiwisesak R, Lu Y, Behar S mBio. 2022; 13(6):e0302022.

PMID: 36409085 PMC: 9765553. DOI: 10.1128/mbio.03020-22.


Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.

Chan Y, Fong S, Poh C, Carissimo G, Yeo N, Amrun S EMBO Mol Med. 2021; 13(6):e14045.

PMID: 33961735 PMC: 8185544. DOI: 10.15252/emmm.202114045.


Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.

Afshar-Sterle S, Zotos D, Bernard N, Scherger A, Rodling L, Alsop A Nat Med. 2014; 20(3):283-90.

PMID: 24487434 DOI: 10.1038/nm.3442.


NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing.

Davis L, Morgan A, Chen J, Snead C, Bloor-Young D, Shenderov E Curr Biol. 2012; 22(24):2331-7.

PMID: 23177477 PMC: 3525857. DOI: 10.1016/j.cub.2012.10.035.


Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Shanker A, Brooks A, Jacobsen K, Wine J, Wiltrout R, Yagita H Cancer Res. 2009; 69(16):6615-23.

PMID: 19654302 PMC: 2727577. DOI: 10.1158/0008-5472.CAN-09-0685.


References
1.
Takayama H, Trenn G, HUMPHREY Jr W, Bluestone J, Henkart P, Sitkovsky M . Antigen receptor-triggered secretion of a trypsin-type esterase from cytotoxic T lymphocytes. J Immunol. 1987; 138(2):566-9. View

2.
Heldin C . Dimerization of cell surface receptors in signal transduction. Cell. 1995; 80(2):213-23. DOI: 10.1016/0092-8674(95)90404-2. View

3.
Leo O, Foo M, Sachs D, Samelson L, Bluestone J . Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A. 1987; 84(5):1374-8. PMC: 304432. DOI: 10.1073/pnas.84.5.1374. View

4.
Ostergaard H, Clark W . The role of Ca2+ in activation of mature cytotoxic T lymphocytes for lysis. J Immunol. 1987; 139(11):3573-9. View

5.
Lancki D, Kaper B, Fitch F . The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL. J Immunol. 1989; 142(2):416-24. View